Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG
发明人:
申请号：
EP19209457.1
公开号：
EP3643309A1
申请日:
2005.12.21
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention relates to the use of indolinones of general formulasubstituted in the 6 position, whereinR1 to R5 and X are defined as in claim 1, the isomers and the salts thereof, particularly the physiologically acceptable salts thereof, as a medicament for the prevention or treatment of specific fibrotic diseases.
